<unk>  is an anthracycline that is FDA approved for the treatment of ovarian cancer, AIDS-related Kaposi's sarcoma, and multiple myeloma. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include asthenia, fatigue, fever, stomatitis, nausea, vomiting, diarrhea, constipation, anorexia, hand-foot syndrome, rash, neutropenia, thrombocytopenia, and anemia.
Doxorubicin liposome
Vincristine liposome
Daunorubicin liposome
Cytarabine liposome
Doxorubicin hydrochloride
Liposomal daunorubicin
Daunorubicin / cytarabine
Taxane